Overview

Ketogenic Diet and Chemotherapy in Affecting Recurrence in Patients With Stage IV Breast Cancer

Status:
Completed
Trial end date:
2020-05-01
Target enrollment:
Participant gender:
Summary
This pilot clinical trial studies how well a ketogenic diet and chemotherapy work in affecting the return of cancer in patients with stage IV breast cancer. Ketogenic diet may be more effective than standard nutrition and may affect quality of life, inflammation, and tumor-related changes. Drugs used in chemotherapy, such as paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving ketogenic diet and chemotherapy may be better in patients with breast cancer.
Phase:
N/A
Details
Lead Sponsor:
Ohio State University Comprehensive Cancer Center
Treatments:
Albumin-Bound Paclitaxel
Paclitaxel